Frankfurt - Delayed Quote EUR
Arrowhead Pharmaceuticals, Inc. (HDP1.F)
14.49
+0.31
+(2.15%)
As of 8:20:02 AM GMT+2. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
545,209
3,551
240,735
243,231
138,287
Operating Expense
663,763
604,631
445,737
421,738
287,323
Operating Income
-118,554
-601,080
-205,002
-178,507
-149,036
Net Non Operating Interest Income Expense
-32,141
-9,632
-3,027
5,033
6,120
Other Income Expense
-1,579
-1,748
1,538
765
2,070
Pretax Income
-152,274
-612,460
-206,491
-172,709
-140,846
Tax Provision
2,402
-2,767
2,784
3,785
2
Net Income Common Stockholders
-143,969
-599,493
-205,275
-176,063
-140,848
Diluted NI Available to Com Stockholders
-143,969
-599,493
-205,275
-176,063
-140,848
Basic EPS
-1.23
-5.00
-1.91
-1.63
-1.36
Diluted EPS
-1.24
-5.00
-1.92
-1.67
-1.36
Basic Average Shares
126,660
119,784
107,312
105,960
103,745
Diluted Average Shares
127,263
119,784
107,312
105,960
103,745
Total Operating Income as Reported
-118,554
-601,080
-205,002
-178,507
-149,036
Total Expenses
663,763
604,631
445,737
421,738
287,323
Net Income from Continuing & Discontinued Operation
-143,969
-599,493
-205,275
-176,063
-140,848
Normalized Income
-143,969
-599,493
-205,275
-176,063
-140,848
Interest Income
30,885
22,720
15,299
5,033
6,120
Interest Expense
63,026
32,352
18,326
0
0
Net Interest Income
-32,141
-9,632
-3,027
5,033
6,120
EBIT
-89,248
-580,108
-188,165
-172,709
-140,846
EBITDA
-68,122
-561,513
-175,672
-162,288
-132,579
Reconciled Depreciation
21,126
18,595
12,493
10,421
8,267
Net Income from Continuing Operation Net Minority Interest
-143,969
-599,493
-205,275
-176,063
-140,848
Normalized EBITDA
-68,122
-561,513
-175,672
-162,288
-132,579
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
9/30/2021 - 1/20/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade